SATC·C is a national reference center dedicated to the promotion of Research, Education and Innovation. We strive to ensure uniformity and state of the art treatment of Advanced Adenomas and Early Colorectal Cancers.
Our activities are based on Research, Clinical Excellence, Education, Innovation & Quality Assessment. The SATC·C (Store Adenomer Tidlige Cancere) was established in 2013 and we are funded by the Region of Southern Denmark.
Our research unit is focused on reducing colorectal cancer death and introducing minimal invasive surgery (MIS) without compromising overall survival.
We are dedicated to advancing prevention, early detection, and minimally invasive treatment of colorectal cancer. Our research spans across all stages—primary, secondary, and tertiary prevention—with innovative clinical trials and interdisciplinary collaboration at its core.
It seems obvious that significant progress in survival will come from primary prevention and earlier detection rather than from more advanced treatment of late cases.
Nature-Inspired Prevention Through Dietary Compounds
We explore how naturally occurring compounds can help reduce the risk of colorectal cancer before it begins. In particular, we study polyacetylenes such as falcarinol (FaOH) and falcarindiol (Fa2OH)—bioactive substances found in carrots.
Next-Generation Screening with Capsule Colonoscopy
Improving how we detect colorectal cancer early is one of our highest priorities. At SATCC, we are at the forefront of research into capsule-based colonoscopy — a non-invasive, camera-equipped capsule that patients swallow, offering a gentler alternative to traditional endoscopy.
Minimally Invasive Approaches to Early Cancers
When colorectal cancer is detected early, less invasive treatments may be possible. At SATC-C, we are exploring how best to manage large adenomas and early-stage cancers using transanal, organ-preserving techniques. These approaches minimise surgical trauma while ensuring thorough cancer treatment.
The Surgical Department A of Odense University Hospital (OUH) provides state of the art diagnosis and treatment of colorectal tumors. Education in advanced endoscopic procedures of the medical staff is a priority. The used equipment is also the latest using the newest technologies.
The SATC·C is hosting various courses, an international symposium, and a congress.
The database of endoscopically removed tumors delivers bi-annually status reports on complications, recurrence and completeness of treatment. The SATC·C will provide ongoing reports to ensure and monitor the quality of performed endoscopic examinations/operations.
We will continuously, in collaboration with industrial partners, evaluate the advantages and disadvantages of equipment under development.
